At any rate, I think we can finally put the myth that there is something fundamentally "rancid" about shine's WIP and cashflow numbers firmly behind us, as these metrics are improving. It would be interesting to get the opinion of some of the previous naysayers on these issues on the most recent numbers....
- Forums
- ASX - By Stock
- SHJ
- Ann: 2018 Annual Report
Ann: 2018 Annual Report, page-18
Featured News
Add SHJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
85.0¢ |
Change
-0.010(1.16%) |
Mkt cap ! $148.9M |
Open | High | Low | Value | Volume |
86.0¢ | 86.0¢ | 85.0¢ | $24.3K | 28.48K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 85.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
86.5¢ | 300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.850 |
1 | 19880 | 0.815 |
1 | 10000 | 0.810 |
2 | 3474 | 0.800 |
2 | 1948 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.865 | 300 | 1 |
0.870 | 10000 | 1 |
0.875 | 348 | 1 |
0.880 | 3410 | 1 |
0.890 | 44140 | 1 |
Last trade - 14.57pm 13/11/2024 (20 minute delay) ? |
Featured News
SHJ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online